Fundraising Fox

Cognos Therapeutics

Inglewood, US · Delaware corporation

Biotech

Founders & leadership

FA
Frank AdellNamed on SEC filing
TC
Thomas ChenNamed on SEC filing
JS
Josh ShacharNamed on SEC filing

Board

EG
Eli GangBoard director
RL
Richard LernerBoard director
WW
Winston WuBoard director

Reported raises · per SEC filings

Form D private placements

$6M disclosed across 8 of 9 rounds · 2015–2026

▶$250KraisedJul 2026 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank AdellExecutive Officer, Director
  • Thomas ChenDirector
  • Eli GangDirector
Offering amount
$2M
Amount sold
$250K
Minimum investment
$10K
First sale
May 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MofferedMar 2022 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Eli GangDirector
  • Josh ShacharDirector
  • Frank AdellExecutive Officer, Director
  • Thomas ChenDirector
Offering amount
$2.1M
Minimum investment
$10K
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$55.3KraisedOct 2021 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Frank AdellExecutive Officer, Director
  • Josh ShacharDirector
  • Thomas ChenDirector
  • Eli GangDirector
Offering amount
$3M
Amount sold
$55.3K
Minimum investment
$55.3K
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$600KraisedJul 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Winston WuDirector
  • Frank AdellExecutive Officer, Director
  • Thomas ChenDirector
  • Richard LernerDirector
  • Eli GangDirector
  • Josh ShacharDirector
Offering amount
$600K
Amount sold
$600K
Minimum investment
$600K
First sale
Jun 2021
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.8MraisedMay 2021 · 117 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard LernerDirector
  • Thomas ChenDirector
  • Eli GangDirector
  • Frank AdellExecutive Officer, Director
  • Josh ShacharDirector
  • Winston WuDirector
Offering amount
$14.3M
Amount sold
$3.8M
Minimum investment
$2K
First sale
Feb 2018
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedDec 2020 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Roger Kornberg, Ph.D.Director
  • Frank AdellExecutive Officer, Director
  • Thomas ChenDirector
  • Eli GangDirector
  • Josh ShacharDirector
  • Richard LernerDirector
Offering amount
$1M
Amount sold
$1M
Minimum investment
$1M
First sale
Dec 2020
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$66.9KraisedMay 2018 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas ChenDirector
  • Roger KornbergDirector
  • Richard LernerDirector
  • Josh ShacharDirector
  • Eli GangDirector
  • Frank AdellExecutive Officer, Director
Offering amount
$1.6M
Amount sold
$66.9K
Minimum investment
$9.6K
First sale
May 2018
Incorporated
Corporation, Nevada, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$48KraisedApr 2016 · 2 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas ChenExecutive Officer, Director
  • Eli GangDirector
  • Roger Kornberg, Ph.D.Director
  • Josh ShacharExecutive Officer, Director
  • Frank (aka Farokh) Adell (aka Adelzadeh)Executive Officer, Director
  • Ronald SolarDirector
Offering amount
$880K
Amount sold
$48K
Minimum investment
$16K
First sale
Apr 2016
Incorporated
Corporation, Nevada, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Cognos Therapeutics raised?
Cognos Therapeutics has disclosed $6M raised across 8 of its 9 known rounds.
Where is Cognos Therapeutics headquartered?
Cognos Therapeutics is headquartered in Inglewood, US.